top of page
Impavido® (miltefosine) is an FDA-approved treatment for cutaneous, mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO
SITE IS MEANT FOR HEALTHCARE PROFESSIONALS ONLY
*U.S. residents only
®
Profile
Join date: Mar 14, 2026
About
0 likes received
0 comments received
0 best answers
A seasoned medical device consultant specializing in regulatory compliance, quality management, and market entry strategies. Expert in FDA, EU MDR, and ISO 13485 standards, guiding manufacturers through approvals, labeling, and risk management. Provides tailored solutions for seamless product commercialization, ensuring compliance and efficiency in global medical device markets.
Saanvi Singh
More actions
bottom of page
